Immunology
News
Bedside asthma medication delivery tied to lower ED readmissions
A bedside medication delivery service ensured that most children hospitalized with asthma left with medications in hand, helping prevent 30-day...
News
Asthma hospitalizations linked to prevalence of common cold in children
Conference Coverage
ACIP recommends LAIV as an option for all people with egg allergies
Live attenuated influenza vaccine will likely be recommended as an option for all individuals with egg allergies, regardless of the severity of...
News
Watch for failure to thrive in children with eosinophilic esophagitis
Be on the lookout for failure to thrive among pediatric patients with eosinophilic esophagitis.
Conference Coverage
SDEF: Have higher degree of suspicion for pediatric allergic contact dermatitis
“Skin testing or blood testing for food allergies, unless very strongly positive, usually aren’t helpful in the management of the atopic...
News
High-dose vitamin D in pregnancy fails to prevent wheezing risk in children
Among pregnant women at high risk for having a child with asthma, high doses of vitamin D administered during the third trimester failed to...
Conference Coverage
VIDEO: Treating your atopic dermatitis patients more effectively
Dr. Adam Friedman discusses simple but effective ways to improve treatment of patients with atopic dermatitis at the 2016 ODAC annual meeting.
News
Single and double dose of MenACWY-CRM series are immunogenic
Both single-dose and two-dose meningococcal CRM-conjugate vaccine series (MenACWY-CRM) were immunogenic, but antibody responses were greater in...
News
Many physicians don’t teach epinephrine use for food allergies
Many pediatricians and allergists failed to provide instructions for when and how to use epinephrine and a written emergency action plan to the...
News
PPIs caused remission in about half of esophageal eosinophilia cases
About half of patients with symptomatic esophageal eosinophilia achieved complete clinical and histologic remission on proton pump inhibitors,...
News
Reslizumab: FDA panel recommends approval for adults, but not children
An FDA advisory committee voted to approve reslizumab, a Teva-sponsored drug treating severe asthma, for use in patients aged 18 years and older,...